LONDON, Feb. 18, 2021 /PRNewswire/ — Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces it donated over $4 million USD in medicines in 2020 through its global medicine donation program, continuing its long-running commitment to supporting charities that address health issues in underserved communities around the world.

Hikma also announces it has extended and increased donation agreements with its existing partners, Dispensary of HopeDirect Relief and the National Children’s Cancer Society. Additionally, Hikma has established new partnerships with Americares, a global health-focused relief and development organisation that provides medicine, medical supplies and health programs to people affected by poverty or disaster; as well as Brother’s Brother Foundation, which provides essential healthcare, infrastructure, disaster response and education resources to people in 42 countries.

“Hikma is committed to bringing better health to patients and communities around the world,” said Hana Ramadan, Vice President, Corporate Social Responsibility. “With the help of our partners throughout the past year, we have increased our medicine donations to low-income groups, displaced peoples and the uninsured — all of whom faced increased challenges due to the COVID-19 pandemic. By expanding our partnerships with these vital charitable organisations, we will be able to provide broader support for those most in need during this critical time.”

Read More Here…

Share on facebook
Share on twitter
Share on reddit
Share on pinterest
Share on email

Bud Digest